1	Antiapoptotic	_	JJ	_	_	2	NMOD	_	_
2	effect	_	NN	_	_	0	ROOT	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	coagulation	_	NN	_	_	6	NMOD	_	_
5	factor	_	NN	_	_	6	NMOD	_	_
6	VIIa	_	NN	_	_	3	PMOD	_	_
7	.	_	.	_	_	2	P	_	_
		
1	Binding	_	NN	_	_	17	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	factor	_	NN	_	_	4	NMOD	_	_
4	VIIa	_	NN	_	_	2	PMOD	_	_
5	(	_	(	_	_	6	P	_	_
6	FVIIa	_	NN	_	_	4	PRN	_	_
7	)	_	)	_	_	6	P	_	_
8	to	_	TO	_	_	1	NMOD	_	_
9	its	_	PRP$	_	_	13	NMOD	_	_
10	cellular	_	JJ	_	_	13	NMOD	_	_
11	receptor	_	NN	_	_	13	NMOD	_	_
12	tissue	_	NN	_	_	13	NMOD	_	_
13	factor	_	NN	_	_	8	PMOD	_	_
14	(	_	(	_	_	15	P	_	_
15	TF	_	NN	_	_	13	PRN	_	_
16	)	_	)	_	_	15	P	_	_
17	was	_	VBD	_	_	0	ROOT	_	_
18	previously	_	RB	_	_	17	VMOD	_	_
19	shown	_	VBN	_	_	17	VC	_	_
20	to	_	TO	_	_	19	VMOD	_	_
21	induce	_	VB	_	_	20	IM	_	_
22	various	_	JJ	_	_	25	NMOD	_	_
23	intracellular	_	JJ	_	_	25	NMOD	_	_
24	signaling	_	NN	_	_	25	NMOD	_	_
25	events	_	NNS	_	_	21	VMOD	_	_
26	,	_	,	_	_	25	P	_	_
27	which	_	WDT	_	_	28	VMOD	_	_
28	were	_	VBD	_	_	25	NMOD	_	_
29	thought	_	VBN	_	_	28	VC	_	_
30	to	_	TO	_	_	29	VMOD	_	_
31	be	_	VB	_	_	30	IM	_	_
32	responsible	_	JJ	_	_	31	VMOD	_	_
33	for	_	IN	_	_	32	AMOD	_	_
34	TF-mediated	_	JJ	_	_	36	NMOD	_	_
35	biologic	_	JJ	_	_	36	NMOD	_	_
36	effects	_	NNS	_	_	33	PMOD	_	_
37	,	_	,	_	_	36	P	_	_
38	including	_	VBG	_	_	36	NMOD	_	_
39	angiogenesis	_	NN	_	_	38	PMOD	_	_
40	,	_	,	_	_	39	P	_	_
41	tumor	_	NN	_	_	42	NMOD	_	_
42	metastasis	_	NN	_	_	39	COORD	_	_
43	,	_	,	_	_	42	P	_	_
44	and	_	CC	_	_	42	COORD	_	_
45	restenosis	_	NN	_	_	44	CONJ	_	_
46	.	_	.	_	_	17	P	_	_
		
1	To	_	TO	_	_	10	VMOD	_	_
2	understand	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	mechanisms	_	NNS	_	_	2	VMOD	_	_
5	behind	_	IN	_	_	4	NMOD	_	_
6	these	_	DT	_	_	7	NMOD	_	_
7	processes	_	NNS	_	_	5	PMOD	_	_
8	,	_	,	_	_	10	P	_	_
9	we	_	PRP	_	_	10	VMOD	_	_
10	have	_	VBP	_	_	0	ROOT	_	_
11	examined	_	VBN	_	_	10	VC	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	effect	_	NN	_	_	11	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	FVIIa	_	NN	_	_	14	PMOD	_	_
16	on	_	IN	_	_	13	NMOD	_	_
17	apoptosis	_	NN	_	_	16	PMOD	_	_
18	.	_	.	_	_	10	P	_	_
		
1	Serum	_	NN	_	_	3	NMOD	_	_
2	deprivation-induced	_	JJ	_	_	3	NMOD	_	_
3	apoptosis	_	NN	_	_	7	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	BHK(+TF)	_	NN	_	_	6	NMOD	_	_
6	cells	_	NNS	_	_	4	PMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	characterized	_	VBN	_	_	7	VC	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	apoptotic	_	JJ	_	_	11	NMOD	_	_
11	blebs	_	NNS	_	_	9	PMOD	_	_
12	,	_	,	_	_	11	P	_	_
13	nuclei	_	NNS	_	_	11	APPO	_	_
14	with	_	IN	_	_	13	NMOD	_	_
15	chromatin-condensed	_	JJ	_	_	16	NMOD	_	_
16	bodies	_	NNS	_	_	14	PMOD	_	_
17	,	_	,	_	_	16	P	_	_
18	DNA	_	NN	_	_	19	NMOD	_	_
19	degradation	_	NN	_	_	16	COORD	_	_
20	,	_	,	_	_	19	P	_	_
21	and	_	CC	_	_	19	COORD	_	_
22	activation	_	NN	_	_	21	CONJ	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	caspase	_	NN	_	_	23	PMOD	_	_
25	3	_	CD	_	_	24	NMOD	_	_
26	.	_	.	_	_	7	P	_	_
		
1	FVIIa	_	NN	_	_	3	VMOD	_	_
2	markedly	_	RB	_	_	3	VMOD	_	_
3	decreased	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	number	_	NN	_	_	3	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	cells	_	NNS	_	_	6	PMOD	_	_
8	with	_	IN	_	_	3	VMOD	_	_
9	apoptotic	_	JJ	_	_	10	NMOD	_	_
10	morphology	_	NN	_	_	8	PMOD	_	_
11	and	_	CC	_	_	3	COORD	_	_
12	prevented	_	VBD	_	_	11	CONJ	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	DNA	_	NN	_	_	15	NMOD	_	_
15	degradation	_	NN	_	_	12	VMOD	_	_
16	as	_	IN	_	_	12	VMOD	_	_
17	measured	_	VBN	_	_	16	SUB	_	_
18	by	_	IN	_	_	17	VMOD	_	_
19	means	_	NNS	_	_	18	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	TdT-mediated	_	JJ	_	_	25	NMOD	_	_
22	dUTP	_	NN	_	_	25	NMOD	_	_
23	nick	_	NN	_	_	25	NMOD	_	_
24	end	_	NN	_	_	25	NMOD	_	_
25	labeling	_	NN	_	_	20	PMOD	_	_
26	(	_	(	_	_	27	P	_	_
27	TUNEL	_	NN	_	_	25	PRN	_	_
28	)	_	)	_	_	27	P	_	_
29	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	antiapoptotic	_	JJ	_	_	3	NMOD	_	_
3	effect	_	NN	_	_	6	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	FVIIa	_	NN	_	_	4	PMOD	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	confirmed	_	VBN	_	_	6	VC	_	_
8	by	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	observation	_	NN	_	_	8	PMOD	_	_
11	that	_	IN	_	_	10	NMOD	_	_
12	FVIIa	_	NN	_	_	13	VMOD	_	_
13	attenuated	_	VBD	_	_	11	SUB	_	_
14	caspase	_	NN	_	_	16	NMOD	_	_
15	3	_	CD	_	_	16	NMOD	_	_
16	activation	_	NN	_	_	13	VMOD	_	_
17	.	_	.	_	_	6	P	_	_
		
1	FVIIa-induced	_	JJ	_	_	3	NMOD	_	_
2	antiapoptotic	_	JJ	_	_	3	NMOD	_	_
3	effect	_	NN	_	_	4	VMOD	_	_
4	was	_	VBD	_	_	0	ROOT	_	_
5	dependent	_	JJ	_	_	4	VMOD	_	_
6	on	_	IN	_	_	5	AMOD	_	_
7	its	_	PRP$	_	_	9	NMOD	_	_
8	proteolytic	_	JJ	_	_	9	NMOD	_	_
9	activity	_	NN	_	_	6	PMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	TF	_	NN	_	_	10	CONJ	_	_
12	but	_	CC	_	_	5	COORD	_	_
13	independent	_	JJ	_	_	12	CONJ	_	_
14	of	_	IN	_	_	13	AMOD	_	_
15	factor	_	NN	_	_	16	NMOD	_	_
16	Xa	_	NN	_	_	14	PMOD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	thrombin	_	NN	_	_	17	CONJ	_	_
19	.	_	.	_	_	4	P	_	_
		
1	FVIIa-induced	_	JJ	_	_	3	NMOD	_	_
2	cell	_	NN	_	_	3	NMOD	_	_
3	survival	_	NN	_	_	4	VMOD	_	_
4	correlated	_	VBD	_	_	0	ROOT	_	_
5	with	_	IN	_	_	4	VMOD	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	activation	_	NN	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Akt	_	NN	_	_	8	PMOD	_	_
10	and	_	CC	_	_	4	COORD	_	_
11	was	_	VBD	_	_	10	CONJ	_	_
12	inhibited	_	VBN	_	_	11	VC	_	_
13	markedly	_	RB	_	_	12	VMOD	_	_
14	by	_	IN	_	_	12	VMOD	_	_
15	the	_	DT	_	_	18	NMOD	_	_
16	specific	_	JJ	_	_	18	NMOD	_	_
17	PI3-kinase	_	NN	_	_	18	NMOD	_	_
18	inhibitor	_	NN	_	_	14	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	LY294002	_	NN	_	_	18	APPO	_	_
21	.	_	.	_	_	4	P	_	_
		
1	Blocking	_	VBG	_	_	25	VMOD	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	activation	_	NN	_	_	1	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	p44/42	_	NN	_	_	8	NMOD	_	_
6	mitogen-activated	_	JJ	_	_	8	NMOD	_	_
7	protein	_	NN	_	_	8	NMOD	_	_
8	kinase	_	NN	_	_	4	PMOD	_	_
9	(	_	(	_	_	10	P	_	_
10	MAPK	_	NN	_	_	8	PRN	_	_
11	)	_	)	_	_	10	P	_	_
12	by	_	IN	_	_	3	NMOD	_	_
13	the	_	DT	_	_	21	NMOD	_	_
14	specific	_	JJ	_	_	21	NMOD	_	_
15	mitogen-induced	_	JJ	_	_	17	NMOD	_	_
16	extracellular	_	JJ	_	_	17	NMOD	_	_
17	kinase	_	NN	_	_	21	NMOD	_	_
18	(	_	(	_	_	19	P	_	_
19	MEK	_	NN	_	_	17	PRN	_	_
20	)	_	)	_	_	19	P	_	_
21	inhibitor	_	NN	_	_	12	PMOD	_	_
22	,	_	,	_	_	21	P	_	_
23	U0126	_	NN	_	_	21	APPO	_	_
24	,	_	,	_	_	21	P	_	_
25	impaired	_	VBD	_	_	0	ROOT	_	_
26	modestly	_	RB	_	_	25	VMOD	_	_
27	the	_	DT	_	_	28	NMOD	_	_
28	ability	_	NN	_	_	25	VMOD	_	_
29	of	_	IN	_	_	28	NMOD	_	_
30	FVIIa	_	NN	_	_	29	PMOD	_	_
31	to	_	TO	_	_	28	NMOD	_	_
32	promote	_	VB	_	_	31	IM	_	_
33	cell	_	NN	_	_	34	NMOD	_	_
34	survival	_	NN	_	_	32	VMOD	_	_
35	.	_	.	_	_	25	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	conclusion	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	8	P	_	_
4	FVIIa	_	NN	_	_	8	VMOD	_	_
5	binding	_	VBG	_	_	4	APPO	_	_
6	to	_	TO	_	_	5	VMOD	_	_
7	TF	_	NN	_	_	6	PMOD	_	_
8	provided	_	VBD	_	_	0	ROOT	_	_
9	protection	_	NN	_	_	8	VMOD	_	_
10	against	_	IN	_	_	9	NMOD	_	_
11	apoptosis	_	NN	_	_	10	PMOD	_	_
12	induced	_	VBN	_	_	11	APPO	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	growth	_	NN	_	_	16	NMOD	_	_
15	factor	_	NN	_	_	16	NMOD	_	_
16	deprivation	_	NN	_	_	13	PMOD	_	_
17	,	_	,	_	_	8	P	_	_
18	primarily	_	RB	_	_	19	PMOD	_	_
19	through	_	IN	_	_	8	VMOD	_	_
20	activation	_	NN	_	_	19	PMOD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	PI3-kinase/Akt	_	NN	_	_	23	NMOD	_	_
23	pathway	_	NN	_	_	21	PMOD	_	_
24	,	_	,	_	_	8	P	_	_
25	and	_	CC	_	_	8	COORD	_	_
26	to	_	TO	_	_	8	VMOD	_	_
27	a	_	DT	_	_	29	NMOD	_	_
28	lesser	_	JJR	_	_	29	NMOD	_	_
29	extent	_	NN	_	_	26	PMOD	_	_
30	,	_	,	_	_	8	P	_	_
31	p44/42	_	CD	_	_	33	NMOD	_	_
32	MAPK	_	NN	_	_	33	NMOD	_	_
33	pathway	_	NN	_	_	8	VMOD	_	_
34	.	_	.	_	_	8	P	_	_
		
